Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative | Molecular Psychiatry
Associations of plasma p-tau181 baseline levels and longitudinal... | Download Scientific Diagram
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer's disease | medRxiv
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals | medRxiv
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration | Nature Medicine
Association of plasma P-tau181 with CSF P-tau181 and Aβ PET (a)... | Download Scientific Diagram
Phospho-TAU (Thr181) cellular HTRF kit | Cisbio
Plasma pTau181 as a biomarker for Alzheimer's disease - Meng - 2020 - MedComm - Wiley Online Library
Phospho-Tau (Thr181) antibody (28866-1-AP) | Proteintech
![Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine](https://www.thelancet.com/cms/asset/40dffde0-5333-4ccf-9aee-5eca64f597b8/gr1.jpg "Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine")
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration | Nature Medicine
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients | mdCurrent India
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease | PLOS ONE
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease | Alzheimer's Research & Therapy | Full Text
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status | Translational Psychiatry
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study - The Lancet Neurology
IJMS | Free Full-Text | Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration
